Safety and activity of brentuximab vedotin (BV) plus ifosfamide, carboplatin, and etoposide (ICE) for relapsed/refractory (Rel/Ref) classical Hodgkin lymphoma (cHL): Initial results of a phase I/II trial Meeting Abstract
| Authors: | Cassaday, R. D.; Fromm, J.; Cowan, A. J.; Libby, E. N. 3rd; Philip, M.; Behnia, S.; Nartea, M.; Press, O.; Gopal, A. K. |
| Abstract Title: | Safety and activity of brentuximab vedotin (BV) plus ifosfamide, carboplatin, and etoposide (ICE) for relapsed/refractory (Rel/Ref) classical Hodgkin lymphoma (cHL): Initial results of a phase I/II trial |
| Meeting Title: | 58th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 128 |
| Issue: | 22 |
| Meeting Dates: | 2016 Dec 3-6 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2016-12-02 |
| Language: | English |
| ACCESSION: | WOS:000394452308014 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V128.22.1834.1834 |
| Notes: | Meeting Abstract: 1834 -- Source: Wos |
